Preoperative clinical radioimmunodetection of pancreatic cancer by 111In-labeled chimeric monoclonal antibody Nd2

Japanese Journal of Cancer Research

Volumn 90, Issue 10, 1999, Pages 1179-1186

  Sawada, Tetsuji ^a   Nishihara, Tamahiro ^a   Yamamoto, Atsushi ^a   Teraoka, Hitoshi ^a   Yamashita, Yoshito ^a   Okamura, Terue ^a   Ochi, Hironobu ^a   Ho, Jenny J L ^b   Kim, Young Sik ^b   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chimeric monoclonal antibody; Nd2; Pancreatic cancer; Radioimmunodetection

Indexed keywords

CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY IN 111;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032729074     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00693.x     Document Type: Article

References (28)

1. Chung, Y. S., Ho, J. J. L., Kim, Y. S., Tanaka, H., Nakata, B., Hiura, A., Motoyoshi, H., Satake, K. and Umeyama, K. The detection of a pancreatic cancer associated antigen in the serum of cancer patients. Cancer, 60, 1636-1643 (1987).
2. Goldenberg, D. M. Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies. Am. J. Gastroenterol., 86, 1392-1403 (1991).
3. Winzelberg, G. G., Grossman, S. J., Rizk, S., Joyce, J. M., Hill, J. B., Atkinson, D. P., Sudina, K., Anderson, K., McElwain, D. and Jones, A. M. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response. Cancer, 69, 1656-1663 (1992).
4. Nabi, H. A. and Doerr, R. J. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspective. Am. J. Surg., 163, 448-456 (1992).
5. Ho, J. J. L., Bi, N., Yan, P. S., Norton, K. A. and Kim, Y. S. Characterization of new pancreatic cancer reactive monoclonal antibodies directed against purified mucin. Cancer Res., 51, 372-380 (1991).
6. [1]In-labeled monoclonal antibody Nd2. Antib. Immunoconjug. Radiopharm., 4, 493-494 (1991).
7. [1]In-labeled monoclonal antibody Nd2 in patients with pancreatic cancer. Jpn. J. Cancer Res., 88, 427-434 (1997).
8. Kondo, Y., Chung, Y.-S., Sawada, T., Inui, A., Yamashita, Y., Hirayama, K., Nakata, B., Ho, J. J. L., Kim, Y. S. and Sowa, M. Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts. Jpn. J. Cancer Res., 86, 1072-1079 (1995).
9. [3]I-labeled monoclonal antibody Nd2 in xenografted nude mice. Jpn. J. Cancer Res., 87, 977-984 (1996).
10. Yasukawa, K., Kaneko, T., Iba, Y., Sawada, T., Sowa, M., Ho, J. J. L., Kim, Y. S. and Chung, Y. S. Preparation of mouse-human chimeric antibody against pancreatic cancer-associated mucin. Int. J. Oncol., 6, 1047-1052 (1995).
11. Hirayama, K., Chung, Y. S., Sawada, T., Kim, Y. S. and Sowa, M. Characterization and biodistribution of a mouse/human chimeric antibody directed against pancreatic cancer mucin. Cancer, 75 (Suppl.), 1545-1553 (1995).
12. Katyal, S., Kramer, E. L., Noz, M. E., McCauley, D., Chachona, A. and Steinfield, A. Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer. Cancer Res., 55 (Suppl.), 5759s-5763s (1995).
13. Maguire, R. T., Pascucci, V. L., Maroli, A. N. and Gulfo, J. V. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer - results with site specific immunoconjugates. Cancer, 72, 3453-3462 (1993).
14. Klapdor, R. and Montz, R. Radioimmunodiagnosis of pancreatic cancer disease. Int. J. Pancreatol., 9, 99-111 (1991).
15. Abdel-Nabi, H. H., Schwartz, A. N., Wechter, D. G., Higano, C. S., Ortman-Nabi, J. A. and Unger, M. W. Scintigraphic detection of gastric and pancreatic carcinoma with In-111 ZCE025 monoclonal antibody. World J. Surg., 15, 122-127 (1991).
16. Boulianne, G. L., Hozumi, N. and Schulman, M. J. Production of functional chimeric mouse/human antibody. Nature, 312, 643-646 (1984).
17. Morrison, S. L., Johnson, M. J., Herzenberg, L. A. and Oi, V. T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. USA, 81, 6851-6855 (1984).
18. Juweid, M., Sharkey, R. M., Markowitz, A., Behr, T., Swayne, L. C., Dunn, R., Hansen, H. J., Shevitz, J., Leung, S. O., Rubin, A. D., Herskovic, T., Hanley, D. and Goldenberg, D. M. Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. Cancer Res., 55 (Suppl.), 5899s-5907s (1995).
19. Sharkey, R. M., Goldenberg, D. M., Vagg, R., Pawlyk, D., Wong, G. Y., Siegel, J. A., Murthy, S., Levine, G. M., Izon, D., Gascon, P., Burger, K., Swayne, L. C. and Hansen, H. J. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon specific antigen-P for targeting gastrointestinal carcinomas. Cancer, 73, 864-877 (1994).
20. Pimm, M. V., Perkins, A. C., Armitage, N. C. and Baldwin, R. W. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody to cancer patients. J. Nucl. Med., 26, 1011-1023 (1985).
21. Herlyn, D., Herlyn, M. and Steplewski, Z. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur. J. Immunol., 9, 657-661 (1979).
22. Liu, A. Y., Robinson, R. R., Hellstrom, K. E., Murray, E. D., Chang, C. P. and Hellstrom, I. Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc. Natl. Acad. Sci. USA, 84, 3439-3443 (1987).
23. Pullyblank, A. M., Guillou, P. J. and Monson, J. R. T. m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer. Br. J. Cancer, 70, 753-758 (1994).
24. Velders, M. P., Litvinov, S. V., Warnaar, S. O., Gorter, A., Fleuren, G. J., Zurawski, V. R. and Coney, L. R. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency. Cancer Res., 54, 1753-1759 (1994).
25. Coney, L. R., Mezzanzanica, D., Sanborn, D., Casalini, P., Colnaghi, M. I. and Zurawski, V. R., Jr. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res., 54, 2448-2455 (1994).
26. Nishihara, T., Chung, Y. S., Sawada, T., Yamashita, Y., Ho, J. J. L., Kim, Y. S. and Sowa, M. Biological benefit of chimeric anti-pancreatic cancer antibody Nd2 for radioimmunotherapy. Proc. Am. Assoc. Cancer Res., 38, 487 (1997).
27. Sperti, C., Pasquali, C., Piccoli, A. and Perdrazzoli, S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J. Surg., 21, 195-200 (1997).
28. Conlon, K. C., Klimstra, D. S. and Brennan, M. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann. Surg., 223, 273-279 (1996).